InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,283.60
(
-0.64%
)
Dow Jones
39,134.76
(
0.77%
)
Brent Oil
84.89
(
-0.14%
)
Bitcoin
64,906.01
(
0.13%
)
Post# of 252279
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

kris_kade

Send PM Follow Ignore
Followers 22
Posts 1671
Boards Moderated 0
Alias Born 12/12/2006

kris_kade

Re: mcbio post# 185660

Thursday, 01/08/2015 7:39:36 AM

Thursday, January 08, 2015 7:39:36 AM

Post# of 252279
CYNAF (Cynapsus Pharma, a Canadian co) is IMO, a better value in treatment of Parkinson's on/off episodes. Their MOA is sublingual vs inhaling that Civitas (private co) has which recently acquired by ACOR at substantial premium.

Cynapsus recently published impressive trial results that clearly showed safety and efficacy. They have scheduled meetings with FDA next month for discussions on P3 trial design

Disclaimer: Long on CYNAF
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up